Charmacy Pharmaceutical Plans Key Shareholder Meeting on New Agreements

Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.

Charmacy Pharmaceutical Co., Ltd. has announced an extraordinary general meeting scheduled for December 27, 2024, where shareholders will consider resolutions related to new sales and purchase framework agreements with Jiangyao Group. The agreements involve the distribution and purchase of medicines, medical devices, and healthcare products, aiming to streamline transactions and enhance their business partnership. Shareholders are encouraged to participate and exercise their voting rights in this strategic decision-making process.

For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.